A client taking diltiazem, a calcium channel blocker, for hypertension has come to the clinic for a follow-up appointment. The nurse will assess the client for which adverse effects?
Chest pain and pale skin
Shortness of breath and wheezing
Peripheral edema and bradycardia
Tachycardia and anxiety
The Correct Answer is C
A. Chest pain and pale skin are not typical adverse effects associated with diltiazem use.
B. Shortness of breath and wheezing may occur due to other conditions or medications but are not common adverse effects of diltiazem.
C. Calcium channel blockers like diltiazem can cause peripheral edema due to vasodilation and bradycardia as a result of their action on the heart rate. Monitoring for these effects is essential in patients taking diltiazem.
D. Tachycardia is not an expected adverse effect of diltiazem; in fact, it is used to manage conditions where tachycardia may be present. Anxiety is also not a direct adverse effect of this medication.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is C
Explanation
A. Short-acting insulin does not cover basal needs; that is the role of long-acting insulin.
B. Intermediate-acting insulin does not primarily cover mealtime glucose spikes; it provides a more prolonged effect.
C. Short-acting insulin is used to manage blood glucose during meals, while intermediate-acting insulin helps maintain glucose control between meals and overnight, making this the correct choice.
D. Short-acting and intermediate-acting insulins have different onset and peak times; they do not share the same pharmacokinetic properties.
Correct Answer is A
Explanation
A. Lorazepam is a benzodiazepine commonly used to manage alcohol withdrawal symptoms, including seizures. It acts quickly to reduce anxiety and seizure activity.
B. Phenytoin is primarily used for seizure control in conditions such as epilepsy but is not the first-line treatment for alcohol withdrawal seizures.
C. Ethosuximide is specifically used for absence seizures and is not effective for alcohol withdrawal.
D. Gabapentin is sometimes used for neuropathic pain but is not indicated for acute alcohol withdrawal or seizure management.